2019-NCOV DISEASE

Clinical trials for 2019-NCOV DISEASE explained in plain language.

Never miss a new study

Get alerted when new 2019-NCOV DISEASE trials appear

Sign up with your email to follow new studies for 2019-NCOV DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Heartburn & arthritis drugs tested as potential COVID-19 fighters

Disease control Completed

This trial tested whether a combination of two existing drugs (famotidine and celecoxib) could help hospitalized COVID-19 patients recover faster and prevent severe illness in newly infected people. The study was small, with only 4 total participants, and aimed to see if this dru…

Matched conditions: 2019-NCOV DISEASE

Phase: PHASE2 • Sponsor: Leidos Life Sciences • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

2019-NCOV DISEASE

Get alerted when new 2019-NCOV DISEASE trials appear

Heartburn & arthritis drugs tested as potential COVID-19 fighters